Researchers use computer simulations to study the impact of high-energy protons on DNA
Read article: Simulations shed light on mechanisms of DNA damage during proton therapy
UK researchers are modelling laser-accelerated proton delivery to test whether inter-track interactions could occur with ultrahigh-dose rate irradiation
Read article: Laser-accelerated proton irradiation: simulating physical and chemical effects
Optimization framework designs ridge filters and spot maps to meet the unique demands of ultrahigh-dose-rate radiation therapy
Read article: Patient-specific ridge filters enable conformal FLASH proton therapy
National Physical Laboratory metrologists have built a primary-standard proton calorimeter and used it to perform dosimetry on FLASH proton beams
Read article: NPL introduces absolute dosimetry for FLASH proton beams
A new cancer treatment called proton minibeam radiation therapy shows promise for destroying tumours while minimizing damage to surrounding healthy tissue
Read article: Proton minibeams could improve treatment of cancer metastases
Researchers identify guidelines for proton therapy planning that help avoid regions of high linear energy transfer outside of target volumes
Read article: Proton therapy planning: how to minimize LET in organs-at-risk
Ultrahigh-dose rate proton therapy proves safe and effective for treating painful bone metastases
Read article: First trial in humans reveals promise of FLASH proton therapy
Researchers use deep learning to map proton dose directly from the low-count data of a compact PET detector
Read article: Neural network verifies proton dose directly from PET detector data
Researchers have developed an algorithm that optimizes pencil-beam delivery patterns, improving FLASH coverage compared with a standard scanning approach
Read article: Optimized pencil-beam delivery patterns enhance FLASH proton therapy
A model that estimates the relative risks of radiation-induced secondary cancer could help optimize particle therapy
Read article: Proton versus carbon-ion therapy: model compares secondary cancer risks
